ALLMedicine™ Severe Acute Respiratory Syndrome Center
Research & Reviews 12,148 results
https://doi.org/10.1089/vim.2021.0187
Viral Immunology; Meidaninikjeh S, Sabouni N et. al.
Jun 30th, 2022 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. COVID-19 has a broad clinical spectrum from asymptomatic patients to multiorgan dysfunction and septic shock. Most of the common symptoms of COV...
https://doi.org/10.3343/alm.2022.42.6.688
Annals of Laboratory Medicine; Kim JA, Bang HI et. al.
Jun 30th, 2022 - Following the original severe acute respiratory syndrome coronavirus 2 strain (Wuhan-Hu-1) in December 2019, the Delta variant in May 2021 and the Omicron variant in December 2021 were classified as variants of concern. The pandemic has been ongoi...
https://doi.org/10.1056/NEJMoa2205011
The New England Journal of Medicine; Cohen-Stavi CJ, Magen O et. al.
Jun 30th, 2022 - Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and specifically against infection with the omicron variant among children 5 to 11 years of age. Using data from the ...
https://doi.org/10.1111/jgs.17945
Journal of the American Geriatrics Society; Bayer TA, DeVone F et. al.
Jun 30th, 2022 - Alzheimer's disease and related dementias (ADRD) impact the diagnosis and infection control of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in nursing homes (NH) by influencing the behavior of residents and their caregivers. Health...
https://doi.org/10.2215/CJN.00830122
Clinical Journal of the American Society of Nephrology : ... Attias P, Azzaoui I et. al.
Jun 29th, 2022 - After two doses of mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients on dialysis show a defective humoral response, but a third dose could increase anti-SARS-CoV-2 spike IgG titers. Responses could be diff...
Guidelines 51 results
https://www.sciencedirect.com/science/article/pii/S0013935121013608?via=ihub
Environmental Research; Zang ST, .
Mar 30th, 2022 - Coronavirus disease 2019 (COVID-19) is induced by a previously undiscovered coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). Since SARS-CoV-2 was first discovered in December 2019, as of Ap...
https://wwwnc.cdc.gov/eid/article/28/5/22-0197_article
Emerging Infectious Diseases; Takahash K, Ishikane M et. al.
Mar 15th, 2022 - To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. ...
https://www.nejm.org/doi/full/10.1056/NEJMc2119912?query=featured_home
The New England Journal of Medicine; Pajon R, .
Jan 26th, 2022 - The highly transmissible omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of mounting concern globally. The omicron variant carries a large number of spike mutations, including at least 15 mutations in...
https://www.nejm.org/doi/full/10.1056/NEJMoa2116414?query=featured_home
The New England Journal of Medicine; Atmar RL, .
Jan 26th, 2022 - In the United States, the significant efficacy of three candidate vaccines — mRNA-1273 (Moderna), Ad26.COV2.S (Johnson & Johnson–Janssen), and BNT162b2 (Pfizer–BioNTech) — against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) result...
https://www.science.org/doi/10.1126/science.abm2052
Science Spudich S, Nath A.
Jan 20th, 2022 - Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a respiratory pathogen, myriad neurologic complications—including confusion, stroke, and neuromuscular disorders—manifest during acute COVID-19. Furthermore, malad...
Drugs 29 results see all →
Clinicaltrials.gov 817 results
https://clinicaltrials.gov/ct2/show/NCT04401436
Jun 24th, 2022 - Coronavirus disease 2019 (COVID-19) is an acute respiratory syndrome caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The emergence of SARS-CoV-2 has led to a pandemic with a wide range of manifestation...
https://clinicaltrials.gov/ct2/show/NCT04582903
Jun 24th, 2022 - In response to the public health emergency posed by the coronavirus disease 2019 (COVID-19) pandemic, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) are leading a large international collaboration to characterize ...
https://clinicaltrials.gov/ct2/show/NCT04794829
Jun 24th, 2022 - Title: Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults after Vaccination Study Description: Yearly influenza vaccination is necessary due to short-lasting influenza immunity and changing strains of circ...
https://clinicaltrials.gov/ct2/show/NCT05430152
Jun 24th, 2022 - There is a growing number of individuals who do not recover to previous levels of health and function following an acute infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but rather develop what has been referred to as 'Lo...
https://clinicaltrials.gov/ct2/show/NCT01200953
Jun 24th, 2022 - Since the fall 2001 distribution of letters containing Bacillus anthracis spores via the US postal system, increased attention has been paid to the evaluation and management of bioterrorism-related illness. Similarly, the emergence of Severe Acute...
News 488 results
https://www.medscape.com/viewarticle/958940
Jun 17th, 2022 - Editor's Note: The information in this quiz is current as of 6/17/2022. For the most recent COVID information, see https://www.medscape.com/resource/coronavirus As of June 2022, there have been 527,211,631 confirmed cases of COVID-19 and 6,289,371...
https://www.medscape.com/viewarticle/975321
Jun 16th, 2022 - Editor's Note: The information in this quiz is current as of 6/16/2022. For the most recent COVID information, see https://www.medscape.com/resource/coronavirus As of June 2022, nearly 6.3 million deaths worldwide were directly attributed to coron...
https://www.mdedge.com/dermatology/article/254041/atopic-dermatitis/effect-dupilumab-sars-cov-2-antibody-response-atopic
Apr 25th, 2022 - Key clinical point: Dupilumab lowered SARS-CoV-2 immunoglobulin G (IgG) antibody levels in unvaccinated patients with atopic dermatitis (AD) and COVID-19 infection; however, it did not impair antibody response in mRNA vaccinated patients with AD.
https://www.mdedge.com/obgyn/article/253625/obstetrics/what-placental-mechanisms-protect-fetus-harm-setting-maternal-covid
Lydia L. Shook, MD
Apr 8th, 2022 - Taglauer ES, Wachman EM, Juttukonda L, et al. Acute severe acute respiratory syndrome coronavirus 2 infection in pregnancy is associated with placental angiotensin-converting enzyme 2 shedding.
https://www.sciencedirect.com/science/article/pii/S0013935121013608?via=ihub
Environmental Research; Zang ST, .
Mar 30th, 2022 - Coronavirus disease 2019 (COVID-19) is induced by a previously undiscovered coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). Since SARS-CoV-2 was first discovered in December 2019, as of Ap...